Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Novartis India
Novartis India
BSE: 500672NSE: NOVARTINDISIN: INE234A01025

17th-Oct-2019 15:33Source: BSE

Novartis India - Compliance Certificate Obtained By Novartis India Limited From A Practising Company Secretary For The Half Year Ended On September 30, 2019, In Terms Of The Provisions Of Regulations 40(9) & (10) Of The SEBI Listing Regulations.

Dear Sir/ Madam,

Please note that in terms of the SEBI Listing Regulations, the Company has obtained a Compliance Certificate from Saraf & Associates, Company Secretaries, for the half year ended on September 30, 2019 and the same is being submitted herewith.

This is for your information and record.

Sections
Follow us on
Available On